Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 356.50M | 359.10M | 336.60M | 253.80M | 73.20M | 329.30M |
Gross Profit | 125.10M | 138.30M | 142.20M | 99.00M | 13.70M | 111.20M |
EBITDA | 52.70M | 55.00M | 49.60M | 48.60M | -22.20M | 43.10M |
Net Income | 10.50M | 9.10M | 7.90M | 7.10M | -48.20M | 160.90M |
Balance Sheet | ||||||
Total Assets | 720.00M | 722.60M | 732.60M | 749.70M | 746.80M | 803.60M |
Cash, Cash Equivalents and Short-Term Investments | 10.20M | 12.20M | 14.10M | 15.60M | 17.10M | 20.30M |
Total Debt | 208.40M | 209.60M | 218.70M | 228.20M | 325.10M | 312.10M |
Total Liabilities | 277.20M | 291.30M | 290.00M | 300.50M | 367.30M | 376.80M |
Stockholders Equity | 442.80M | 431.30M | 442.60M | 449.20M | 379.50M | 426.80M |
Cash Flow | ||||||
Free Cash Flow | 29.20M | 41.10M | 16.80M | 45.40M | -35.80M | -34.60M |
Operating Cash Flow | 54.00M | 68.30M | 47.50M | 71.20M | -19.30M | 13.00M |
Investing Cash Flow | -15.40M | -27.20M | -14.70M | -15.80M | -5.40M | 156.40M |
Financing Cash Flow | -48.80M | -43.00M | -34.30M | -56.90M | 21.50M | -160.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | £263.18M | 6.00 | 10.69% | ― | 0.50% | ― | |
67 Neutral | £42.50B | 37.05 | 21.77% | 1.34% | 7.67% | -15.09% | |
67 Neutral | $42.67B | 15.18 | 35.82% | 3.28% | -3.88% | -11.33% | |
67 Neutral | £827.00M | 14.74 | 16.38% | 0.38% | 3.70% | 57.10% | |
66 Neutral | £10.46B | 6.17 | 4.94% | 3.10% | -0.88% | 2.57% | |
63 Neutral | £322.54M | ― | 3.72% | ― | ― | ||
60 Neutral | £508.59M | 39.29 | 1.27% | 3.72% | 16.73% | -55.22% |